Deferasirox Fe3+ Chelate Research Workflows
2026-08-13
Build reproducible ferric-iron assays with a DMSO-soluble Deferasirox Fe3+ chelate reference material, while keeping preformed-complex effects distinct from free-ligand chelation. The workflow connects iron-overload models with practical controls, exposure windows, and troubleshooting for beta-thalassemia and chronic-anemia research.
CDK4/6–BET Synergy in Pancreatic Cancer
2026-08-13
Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 can overcome a major liability of CDK4/6 blockade in pancreatic ductal adenocarcinoma: enhanced migration, invasion, and epithelial-to-mesenchymal transition. The study links this effect to GSK3β-mediated Wnt/β-catenin activation and identifies disruption of Wnt/β-catenin–TGF-β/Smad crosstalk as a mechanistic basis for combination treatment.
ATRX Deficiency and RTK Inhibitor Sensitivity in Glioma
2026-08-12
The reference study identifies ATRX deficiency as a cellular context associated with increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma models. Its combination data with temozolomide support ATRX-aware interpretation of therapeutic studies, while also highlighting the need for validation beyond cell-based assays.
CPI-613 Workflows for Mitochondrial Cancer Studies
2026-08-12
Use CPI-613 to connect mitochondrial enzyme inhibition with ATP loss, membrane-potential changes, and apoptosis in cancer-cell workflows. This guide distinguishes practical screening recommendations from evidence-led interpretation, including how to test PDHA1-linked signaling and treatment combinations without overclaiming mechanism.
DMG-PEG2000-NH2 for Reliable Cell Assays
2026-08-11
Learn how DMG-PEG2000-NH2 (SKU M2006) can support controlled liposomal and lipid nanoparticle workflows connected to cell viability, proliferation, and cytotoxicity testing. This scenario-based guide covers conjugation chemistry, solvent compatibility, assay controls, data interpretation, and practical product-selection criteria.
Q-VD-OPh for Mitochondrial Apoptosis Imaging
2026-08-10
Q-VD-OPh is a cell-permeable pan-caspase inhibitor that can turn super-resolution imaging of mitochondrial mRNA release into a causal apoptosis assay. This guide connects Q-VD-OPh pharmacology with STED-smFISH and MINFLUX findings to improve experimental design, controls, and interpretation.
Palmitic acid: Protocol and QC Guide
2026-08-09
Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid for controlled studies of lipid metabolism, insulin signaling, inflammation signaling, and protein palmitoylation. It is suitable for solvent-based workflows but should not be used for aqueous stock preparation or long-term storage of solutions, so vehicle controls, prompt use, and documented reconstitution are essential.
AZD6482 PI3Kβ Inhibitor Workflows
2026-08-08
AZD6482 enables selective PI3Kβ perturbation in kinase, platelet, adipocyte, and disease-modeling assays. This guide translates its isoform profile and practical handling requirements into reproducible workflows, while framing DM1 RNA-foci experiments as an exploratory cross-domain application rather than an established therapeutic use.
Dronedarone (Multaq): Cell Assay Guide
2026-08-07
A scenario-based guide to using Dronedarone (Multaq), SKU A3374, in cell viability, proliferation, cytotoxicity, and cardiac pharmacology workflows. It connects solvent handling, assay controls, translational concentration ranges, and vendor-selection criteria to published electrophysiology evidence.
Light-Inducible RNA Switches for Precision Gene Therapy Cont
2026-08-07
A recent study presents a rationally designed light-inducible RNA-releasing protein (LIRP) enabling rapid, reversible translational control of therapeutic genes in vivo. This optogenetic platform offers precise, on-demand gene therapy regulation, with implications for chronic metabolic and retinal diseases requiring spatiotemporal intervention.
CAFs Mediate Prostate Cancer Chemoresistance via ANGPTL4-IQG
2026-08-06
This study reveals that cancer-associated fibroblasts (CAFs) promote chemoresistance in prostate cancer by modulating mitochondrial metabolism through the ANGPTL4-IQGAP1 signaling axis. These findings identify new therapeutic targets and provide mechanistic insight into tumor–stroma metabolic crosstalk.
Prion-Driven Protein Assembly Modulates Adaptive Mutagenesis
2026-08-06
This study uncovers how prion-based protein self-assembly in yeast functions as a reversible, heritable switch regulating mutagenesis, thereby promoting rapid adaptation under selective stress. These findings introduce an epigenetic mechanism for tuning genome stability and have broad implications for research on drug resistance and evolutionary dynamics.
SR 11302: Applied Workflows for AP-1 Transcription Factor In
2026-08-05
SR 11302 offers targeted AP-1 inhibition for cancer research, enabling precise dissection of oncogenic pathways and immune modulation with minimized off-target effects. Its robust selectivity and well-characterized protocol parameters empower reproducible, high-impact studies in chemoprevention and chemotherapeutic discovery.
Betaine Hydrochloride for Robust Metabolic Enzyme Assays
2026-08-05
Betaine hydrochloride (carboxymethyl(trimethyl)azanium chloride) enables reproducible, high-sensitivity metabolic enzyme and protease workflows thanks to its unrivaled solubility and purity. This guide delivers practical, stepwise protocols, advanced troubleshooting, and actionable insights for leveraging APExBIO’s reagent in inflammation-driven disease models.
Harnessing PD98059: MEK Inhibition for Leukemia and Neuropro
2026-08-04
PD98059, a selective and reversible MEK inhibitor, empowers researchers to dissect MAPK/ERK signaling with precision—enabling robust studies in leukemia cell differentiation, cell cycle arrest, and neuroprotection post-ischemia. This article details advanced experimental workflows, practical troubleshooting, and strategic protocol enhancements grounded in translational research.
479 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page